Top Markets
#1 Palladium Network Palladium Network +27.90%
#2 Siren Siren +24.49%
#3 Ankr Network Ankr Network +22.99%
#4 BankrCoin BankrCoin +19.64%
#5 Pons Pons +15.53%
#6 Status Status +11.66%
#7 Wiki Cat Wiki Cat +8.87%
#8 RedStone RedStone +8.25%
#9 Wrapped Aave Ethereum WETH Wrapped Aave Ethereum WETH +7.24%
#10 Hive Hive +7.22%
Coin of the day
Palladium Network Palladium Network
Pengaturan
Bahasa
BAHASA INDONESIA
Mata uang
USD
Tema
Shukra Pharmaceuticals Limited Shukra Pharmaceuticals Limited

Shukra Pharmaceuticals Limited

SHUKRAPHAR
Peringkat dalam Saham #17790
Shukra Pharmaceuticals Limited is a prominent company engaged in the... Shukra Pharmaceuticals Limited is a prominent company engaged in the manufacturing and global distribution of pharmaceutical products. Their comprehensive product line addresses a broad spectrum of medical conditions, encompassing anti-infective medications (such as antibiotics, macrolides, quinolones, antivirals, antifungals, antimalarials, antiprotozoals, and anti-helminthics), central nervous system drugs (including sedatives, tranquilizers, antidepressants, and anti-manic agents), gastrointestinal treatments (like anti-emetics and anti-ulcer drugs), cardiovascular remedies (beta-blockers, diuretics), pain and inflammation management (analgesics, muscle relaxants, corticosteroids), anti-tuberculosis drugs, vitamin supplements, anti-allergy medications, and therapies for metabolic imbalances such as hyper- and hypoglycemia. The company was established on March 4, 1993, and its primary operations are directed from its headquarters in Ahmedabad, India.
Harga Saham
$0.51647906
Terakhir disinkronkan: 2026-09-02
Kapitalisasi Pasar
$226.16M
Perubahan (1 hari)
5.29%
Perubahan (1 tahun)
63.57%
Negara
IN
Perdagangan Shukra Pharmaceuticals Limited (SHUKRAPHAR)

Kategori

Healthcare
Pendapatan untuk Shukra Pharmaceuticals Limited (SHUKRAPHAR)
Pendapatan pada Sep 2026 TTM: 0
Menurut laporan keuangan terbaru dari Shukra Pharmaceuticals Limited, pendapatan saat ini (TTM) adalah 0. Pada tahun 2026, perusahaan menghasilkan pendapatan sebesar 0 sama dengan pendapatan pada tahun 2026 yang sebesar 0. Pendapatan adalah jumlah total yang dihasilkan dari penjualan barang atau jasa. Tidak seperti laba, tidak ada pengeluaran yang dikurangkan.
Riwayat pendapatan Shukra Pharmaceuticals Limited dari 2026 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Pendapatan untuk perusahaan serupa atau pesaing
Perusahaan Pendapatan Perbedaan Pendapatan Negara
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 $2.54B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT
Sino Biopharmaceutical Limited Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited
1177.HK
 $4.88B -
HK